SELECT LANGUAGE BELOW

A recent surge suggests a hidden bull market in this exchange stock, based on the charts.

A recent surge suggests a hidden bull market in this exchange stock, based on the charts.

CME Group Stock Analysis

CME Group (CME) has not performed as well as the S&P 500 since the market hit a low back in April. While the S&P was climbing to new highs during August and September, CME’s stock dropped below important support levels. However, recent movements suggest that CME might be entering a new phase of accumulation, indicating possible future gains for this futures contract.

In August, CME fell below its 50-day moving average and then tested the 200-day moving average, which hovers around $257. As September and October progressed, prices rebounded from that 200-day level, reaffirming support at the lows seen in early September. Throughout October, the Relative Strength Index (RSI) moved within the range of 40 to 60 during what seemed like a correction. A neutral RSI reading and a flat moving average pointed to a trend that was, well, a bit sideways without any strong upward momentum.

Earlier this month, the RSI saw a robust increase, marking a breakout from short-term resistance around $275. This sharp price action, paired with stronger momentum indicators, suggests that CME has likely emerged from its consolidation period into a promising accumulation phase. During the October consolidation, we also observed that the Chaikin Money Flow (CMF) consistently remained above zero. This indicates that while price trends appeared flat, the underlying volume reflected a growing bullish sentiment due to higher closing prices.

The upward trend in the cumulative distribution line lends further credence to this positive volume perspective, implying a sort of unnoticed bullish phase as investors became more engaged with CME during the recent period of stability.

Looking at the weekly chart reveals how these recent price movements fit within CME’s overall upward trajectory. The weekly RSI stayed above 40, and prices approached the 40-week moving average, which aligns closely with the 200-day average. Recently, the weekly PPO indicator displayed a bullish crossover, hinting at CME Group’s successful shift and entry into a new accumulation stage. There seem to be notable parallels between this current uptick and the breakout seen in August 2024, where a breach above trendline resistance led to notable gains in subsequent months.

Considering the recent breakout, the encouraging volume figures, and the bullish outlook on the weekly chart, it appears that CME has room for further growth in this financial infrastructure phase.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News